Evidence map›Paper›PMID 25609355›Full record

ArticleBMC health services research2015

Uterotonic use immediately following birth: using a novel methodology to estimate population coverage in four countries.

Jim Ricca, Vikas Dwivedi, John Varallo, Gajendra Singh, Suranjeen Prasad Pallipamula, Nazir Amade, Maria de Luz Vaz, Dustan Bishanga, Marya Plotkin, Bushra Al-Makaleh and 2 more

Abstract read
In one paragraph

Article in BMC health services research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jim RiccaMaternal and Child Survival Program, Jhpiego, 1776 Massachusetts Ave., NW #300, Washington, DC, 20036, USA. Jim.ricca@jhpiego.org.
Vikas DwivediMaternal and Child Survival Program, JSI Research & Training Institute, Inc, 1776 Massachusetts Ave., NW #300, Washington, DC, 20036, USA. vdwivedi@jsi.com.
John VaralloMaternal and Child Survival Program, Jhpiego, 1776 Massachusetts Ave., NW #300, Washington, DC, 20036, USA. John.varallo@jhpiego.org.
Gajendra SinghJhpiego, 221, Okhla Phase III, New Delhi, 110 020, India. Gajendra.Singh@jhpiego.org.
Suranjeen Prasad PallipamulaMaternal Child Integrated Program (MCHIP), Jhpiego, Government Vaccine Institute Campus, Namkum, Ranchi, Jharkhand, 834010, India. Suranjeen.Pallipamula@jhpiego.org.
Nazir AmadeDirector of Maternal and Child Health, Ministry of Health, Maputo, Mozambique. naibrahimo@yahoo.com.br.
Maria de Luz VazMCHIP, Jhpiego, Maputo, Mozambique. Maria.vaz@jhpiego.org.
Dustan BishangaMCHIP, Jhpiego, PO Box 9170, Dar es Salaam, Tanzania. dustan.bishanga@jhpiego.org.
Marya PlotkinJhpiego Tanzania, PO Box 9170, Dar es Salaam, Tanzania. Marya.plotkin@jhpiego.org.
Bushra Al-MakalehMCHIP, Yemen, Haddah Street, Sana'a City, Yemen. Bushra.Al-Makaleh@jhpiego.org.
Stephanie SuhowatskyMaternal and Child Survival Program, Jhpiego, 1776 Massachusetts Ave., NW #300, Washington, DC, 20036, USA. Stephanie.suhowatsky@jhpiego.org.
Jeffrey Michael SmithMaternal and Child Survival Program, Jhpiego, 1776 Massachusetts Ave., NW #300, Washington, DC, 20036, USA. Jeffrey.Smith@Jhpiego.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPostpartum hemorrhage (PPH) is the leading cause of maternal mortality in developing countries. While incidence of PPH can be dramatically reduced by uterotonic use immediately following birth (UUIFB) in both community and facility settings, national coverage estimates are rare. Most national health systems have no indicator to track this, and community-based measurements are even more scarce. To fill this information gap, a methodology for estimating national coverage for UUIFB was developed and piloted in four settings.

methodsThe rapid estimation methodology consisted of convening a group of national technical experts and using the Delphi method to come to consensus on key data elements that were applied to a simple algorithm, generating a non-precise national estimate of coverage of UUIFB. Data elements needed for the calculation were the distribution of births by location and estimates of UUIFB in each of those settings, adjusted to take account of stockout rates and potency of uterotonics. This exercise was conducted in 2013 in Mozambique, Tanzania, the state of Jharkhand in India, and Yemen.

resultsAvailable data showed that deliveries in public health facilities account for approximately half of births in Mozambique and Tanzania, 16% in Jharkhand and 24% of births in Yemen. Significant proportions of births occur in private facilities in Jharkhand and faith-based facilities in Tanzania. Estimated uterotonic use for facility births ranged from 70 to 100%. Uterotonics are not used routinely for PPH prevention at home births in any of the settings. National UUIFB coverage estimates of all births were 43% in Mozambique, 40% in Tanzania, 44% in Jharkhand, and 14% in Yemen.

conclusionThis methodology for estimating coverage of UUIFB was found to be feasible and acceptable. While the exercise produces imprecise estimates whose validity cannot be assessed objectively in the absence of a gold standard estimate, stakeholders felt they were accurate enough to be actionable. The exercise highlighted information and practice gaps and promoted discussion on ways to improve UUIFB measurement and coverage, particularly of home births. Further follow up is needed to verify actions taken. The methodology produces useful data to help accelerate efforts to reduce maternal mortality.

Indexed as

Maternal MortalityAdultCommunity Health ServicesDelivery RoomsDelphi TechniqueDeveloping CountriesFemaleHumansIncidenceIndiaInfant, NewbornMaleMiddle AgedMidwiferyMozambiqueOxytocicsOxytocics

Identifiers

PMID25609355
PMCPMC4307135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.